Dosing to stop in Phase III clinical study of tominersen following recommendation from an Independent Data Monitoring Committee (iDMC) No new safety signals were identified for tominersen in the iDMC’s review Basel, 22 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the decision to discontinue dosing in the Phase III GENERATION HD1... Read more
First-of-its-kind medium resembles the natural cellular environment found in the human body for more physiologically relevant cell culture models CARLSBAD, Calif., March 22, 2021 /PRNewswire/ — Thermo Fisher Scientific today launched the new Gibco Human Plasma-like Medium (HPLM), the first cell culture medium on the market that mimics the metabolic profile of human plasma that... Read more
Thermo Fisher Scientific Collaborates with Protein Metrics to Optimize Mass Spectrometry Data Analysis for Biopharmaceutical and Proteomics Applications Protein Metrics’ software solutions complement Thermo Fisher’s mass spectrometry systems to facilitate precise, reliable data processing and drive innovation GERMERING, Germany, March 22, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Protein Metrics,... Read more
First Phase III study to show that a cancer immunotherapy improves disease-free survival in people with resectable early stage lung cancer compared to best supportive care Treating lung cancer early, before it has spread, may help prevent the disease from returning and therefore provide the best opportunity for a cure Data will be submitted to... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) (the “Company”) today announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting on May 26, 2021. This... Read more
ONE Pesticide420™ solution delivers enhanced cannabis & hemp testing experience with 70+ ready-to-use certified calibration levels WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched its ONE Pesticide420™ CRM Reagent and Consumable Kit for cannabis & hemp testing. Initially the kits will support pesticide and mycotoxin testing for cannabis &... Read more
Acuity Technology Enables the Possibility to See the 3D Genome in situ and at Single-Cell and Sub-Cellular Resolution SAN JOSE, Calif. & BOSTON–(BUSINESS WIRE)– Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its industry-leading documentation, workflow and decision making Signals™ informatics platform is being expanded to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with Insightful Science, a software company serving the global life sciences community. With... Read more
Thermo Scientific Talos F200E (S)TEM Combines Atomic-Level Imaging with Fast EDS Analysis HILLSBORO, Ore., March 17, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Talos F200E Scanning Transmission Electron Microscope ((S)TEM), combining atomic-level resolution imaging, fast energy dispersive X-ray spectroscopy (EDS) analysis and enhanced data reliability,... Read more